IGF-1R ANTIBODY AND ITS USE IN DIAGNOSING CANCER
AR105553B1Active Publication Date: 2026-08-26PIERRE FABRE MEDICAMENT SAS
View PDF 0 Cites 0 Cited by
Patent Information
- Application Number
- ARP20160101177
- Authority / Receiving Office
- AR · AR
- Patent Type
- Patents
- Current Assignee / Owner
- Priority Date
- 2015-04-27
- Filing Date
- 2016-04-26
- Publication Date
- 2026-08-26
- Estimated Expiration
- 2036-04-26
Abstract
This refers to an antibody, in particular a monoclonal antibody, capable of binding to IGF-1R, as well as to the amino acid and nucleic acid sequences that encode said antibody.
Need to check novelty before this filing date? Find Prior Art
Claims
1. An isolated IGF-1R antibody, or an isolated fragment thereof that binds to antigen, characterized in that it comprises: i) a heavy chain with CDR-H1 of sequence SEQ ID NO: 1, CDR-H2 of sequence SEQ ID NO: 2 and CDR-H3 of sequence SEQ ID NO: 3; and ii) a light chain with CDR-L1 of sequence SEQ ID NO: 4, CDR-L2 of sequence SEQ ID NO: 5 and CDR-L3 of sequence SEQ ID NO:
6. 7 Claims follow